|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Active Biotech AB, of Stockholm, Sweden, said its recent offering of SEK169 million (US$21.4 million) was oversubscribed by 43 percent, increasing the number of shares in the company to a total of 39.4 million. The first day of trading in the new shares will occur on or around July 25. Active Biotech focuses on drugs to treat autoimmune/inflammatory diseases and cancer.
BioSyntech Inc., of Laval, Quebec, signed a letter of intent for Nicholas Piramal India Ltd., of Mumbai, India, to subscribe to 7.5 million of its common shares at a price of C$0.80 (US$0.66) per share. NPIL's post-issue shareholding will be about 17 percent of BioSyntech's issued shares. ...